Indications CerebreMed™

effects of virus infections, including post-COVID conditions.

Consequences of viral infections, including post-covian conditions

improvement against neurological disorders

disturbed concentration of attention

neurological issues associated with the effects of disturbed cerebrovascular circulation such as hemorrhagic and ischemic stroke

support against neurological disorders related to the spine such as prolapsed discs, backache, stenosis, and trauma effects

Vertigo (dizziness)

tinnitus (ear noise)

Ingredients

Available in liquid form.

Storage method:

Contraindications:

individual intolerance to the remedy ingredients, pregnancy, and breastfeeding.

Side effects:

Not identified

Interaction:

Compatible with other medicines

About the manufacturer

LIBI PHARM is a pioneering, privately owned Israeli drug and medical device development company that has created the patented, innovative product Virlaza®️, which could be a breakthrough in the treatment of a number of diseases characterized by acute respiratory failure, including those caused by the COVID-19 coronavirus, as well as a number of immunological disorders.

reduced incidence and severity of migraine attacks (headache), including cluster headache

stabilization of the state following traumatic brain injury

depressed states, anxiety, anxiety disorders, and panic attacks

trigeminal neuralgia and face ache

alleviation of Parkinson and Alzheimer disease

dementia, memory disorders

multiple sclerosis

support related to chronic pain conditions

burning sensation and pain of neurologic etiology

The composition is all-natural (natural): water, octacosanol (Brazil nut); unrefined olive oil (olive oil);

Extracts: jujube tree (Zizyphus jujube), ginkgo biloba leaves -Gb761: flavonol glycosides -24%, ginkgolides of bilobalide - 6%, Aloe Vera, ginger (Zīngiber officinalis), guarana (Paullinia cupana), Melissa (Melissa officinalis), wild passion flower (Passiflóra incarnáta); magnesium (Magnesium), selenium (Selenium);
Remedy contains: octacosanol (policosanol), oleamide; alkaloids: sanjoinine A (CA), nuciferine; ginkgo flavone glycosides, bilobalides, ⍺&b zingiberenes, gingerol; flavonoids: quercetin, isoquercetin, nelumboside, rutin, coumarin, vitexin; C-glycosides of apigenin and luteolin, kaempferol; spinosin, cvertisin, guaranine (guarana caffeine), theophylline, d, l-camphor, cineole, borneol

Shake well before use

In a dry, dark place, out of reach of children, at temperatures between +4°C and +25°C.
The expiration date is on the package.

Action CerebreMed

induces the generation of NGF (hormone of restoring, growth, and defense of neuronal tissue)

reduces and eliminates irritability, nausea, tension, stress, and weakness

induces the secretion of dopamine and serotonin

reduces the effects caused by cerebral ischemia

neutralizes free radicals. Its antioxidant properties reduces the development of atherosclerosis, thus, it improves neuropsychological features such as short-term and long-term memory, speech, reaction rate, and clarity of thinking